Cargando…
RNA‐Peptide nanoplexes drug DNA damage pathways in high‐grade serous ovarian tumors
DNA damaging chemotherapy is a cornerstone of current front‐line treatments for advanced ovarian cancer (OC). Despite the fact that a majority of these patients initially respond to therapy, most will relapse with chemo‐resistant disease; therefore, adjuvant treatments that synergize with DNA‐damagi...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773954/ https://www.ncbi.nlm.nih.gov/pubmed/29376131 http://dx.doi.org/10.1002/btm2.10086 |